Identification of Gastric Cancer Patients by Serum Protein Profiling

Citations Over TimeTop 10% of 2004 papers

Abstract

Using surface-enhanced laser desorption ionization mass spectrometry (SELDI/TOF-MS) and ProteinChip technology, coupled with a pattern-matching algorithm and serum samples, we screened for protein patterns to differentiate gastric cancer patients from noncancer patients. A classifier ensemble, consisting of 50 decision trees, correctly classified all gastric cancers and all controls of a training set (100% sensitivity and 100% specificity). Eight of 9 stage I gastric cancers (88.9% sensitivity for stage I) were correctly classified. In addition, 28 sera from gastric cancer patients taken in different hospitals were correctly classified (100% sensitivity). Furthermore, all 11 control sera obtained from patients without gastric cancer (100% specificity) were classified correctly and 29 of 30 healthy blood-donors were classified as noncancerous. ProteinChip technology in conjunction with bioinformatics allows the highly sensitive and specific recognition of gastric cancer patients.

Related Papers

• → Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type(2007)124 cited
• → Diabetes mellitus increases the risk of early gastric cancer development(2014)53 cited
• → H. pylori infection and the development of gastric cancer(2002)35 cited
• → GASTRIC CANCER DETECTED AFTER HELICOBACTER PYLORI ERADICATION(2007)10 cited
• → Intragastric Bile Acids in Patients with Gastric Ulcer and with Gastric Cancer(1989)1 cited